7 KILLED, HUNDREDS INJURED AS STRONG QUAKE HITS SULAWESI, INDONESIA
VATICAN: POPE FRANCIS, FORMER POPE BENEDICT BOTH GET COVID-19 VACCINE
AUSTRALIA REBUKES GOOGLE FOR BLOCKING LOCAL CONTENT
JAPAN TO BAN ENTRY OF FOREIGN ATHLETES TO TRAIN AHEAD OF SUMMER OLYMPICS
BIDEN INAUGURATION WILL FEATURE DIVERSE PERFORMANCES INCLUDING LADY GAGA, JENNIFER LOPEZ
COURT ORDERS ARREST OF COPS ACCUSED OF KILLING ARMY MEN IN JOLO
THE PANDEMIC SLAMS PHL VEHICLE SALES IN 2020
CHESS PLAYER WESLEY SO BAGS P11.8M, JOINS WORLD’S TOP ESPORT EARNERS
ZSA ZSA PADILLA FINALLY VISITS THE GRAVE OF ‘COMEDY KING’ DOLPHY AGAIN
DUTERTE: PRESIDENCY JOB NOT FOR A WOMEN

EU RESERVES 400 MILLION DOSES OF POTENTIAL J&J COVID-19 VIRUS

7 months ago | World Science & Technology News | 0 comments

By Xai Reyes

The European Union said Thursday it had reserved up to 400 million doses of a potential new coronavirus vaccine developed by US giant Johnson & Johnson.

In a statement, the European Union said preliminary talks concluded on Friday for the first purchase of 200 million doses, followed by an equal number later.

The bloc said it was in “intensive discussions” with other manufacturers for potential vaccines.

According to the World Health Organization, nearly 3.7 million cases of COVID-19 have been recorded in Europe since the start of the pandemic, and 218,383 deaths.

On July 31, the European Commission said it had reserved 300 million doses of another potential vaccine being developed by French firm Sanofi.

0 Comments

Submit a Comment

Your email address will not be published.

Social Media